Search

Your search keyword '"Navazio A"' showing total 1,053 results
Start Over Author "Navazio A"
1,053 results on '"Navazio A"'

155. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

Author

De Luca L., Formigli D., Meessen J., Uguccioni M., Cosentino N., Paolillo C., Di Lenarda A., Colivicchi F., Gabrielli D., Gulizia M. M., Scherillo M., Maras P., Ramani F., Falcone C., Passarelli I., Mauri S., Calabro P., Bianchi R., Di Palma G., Mascia F., Vetrano A., Fusco A., Proia E., Aiello A., Tomai F., Licitra R., Petrolini A., Bosco B., Magliari F., Callerame M., Mazzella T., Lettica G. V., Coco G., Incao F., Marinacci L., D'Addario S., Tartaglione S. N., Ubaldi S., Sanchez F. A., Costa P., Manca G., Failla M., Procaccini V., Senni M., Luminita E. M., Bonomo P., Mossa C., Corda S., Colavita A. R., Trevisonno G., Vizzari G., Formaro C., Nalin I. L., De Rosa F. M., Fontana F., Fuscaldo G. F., Passamonti E., Bertella E., Calvaruso E. V., Varani E., Tani F., Cicchitelli G., Paoloni P., Marziali A., Campo G., Tebaldi M., Biscaglia S., Di Biase M., Brunetti N. D., Gallotta A. M., Mattei L., Marini R., Balsemin F., D'Urbano M., Naio R., Vicinelli P., Arena G., Mazzini M., Gigli N., Miserrafiti B., Monopoli A., Mortara A., Delfino P., Chioffi M. M., Marino P., Gravellone M., Barbieri L., Ledda A., Geraci G., Carmina M. G., Raisaro A. E., Di Giacomo C., Somaschini A., Fasano M. L., Sannazzaro M., Arcieri R., Pantaleoni M., Leuzzi C., Gorlato G., Greco G., Chiera A., Ammaturo T. A., Malanchini G., Del Corral M. P., Tedesco L., Pede S., Urso L. G., Piscione F., Galasso G., Provasoli S., Fattore L., Lucca G., Cresti A., Cardillo A., Fera M. S., Vennettilli F., Gaudio C., Paravati V., Caldarola P., Locuratolo N., Verlato R., De Conti F., Turiano G., Preti G., Moretti L., Silenzi S., Colonna G., Picciolo A., Nicosia A., Cascone C., Di Sciascio G., Mangiacapra F., Russo A., Mastroianno S., Esposito G., Cosmi F., D'Orazio S., Costantini C., Lanari A., De Rosa P., Esposito L., Bilato C., Dalla Valle C., Ceresa M., Colombo E., Pennisi V., Casciola G., Driussi M., Bisceglia T., Scalvini S., Rivadossi F., Volpe M., Comito F., Scorzoni D., Grimoldi P., Lagioia R., Santoro D., De Cesare N., Comotti T., Poli A., Martina P., Musolino M. F., Multari E. I., Bilardo G., Scalchi G., Olivieri C., Caranci F., Pavan D., Ganci G., Mariani A., Falchetti E., Lanzillo T., Caccavale A., Bongo A. S., Rizzi A., Favilli R., Maffei S., Mallardo M., Fulgione C., Bordin F., Bonmassari R., Battaia E., Puzzo A., Vianello G., D'Arpino A., Romei M., Pajes G., Petronzelli S., Ghezzi F., Brigido S., Pignatelli L., Brscic E., Sori P., Russo M., Biancolillo E., Ignone G., De Giorgio N. A., Campaniello C., Ponticelli P., Margonato A., Gerosa S., Cutaia A., Casalicchio C., Bartolomucci F., Larosa C., Spadafina T., Putignano A., Se Cristofaro R., Bernardi L., Sommariva L., Celestini A., Bertucci C. M., Marchetti M., Franceschini Grisolia E., Ammendolea C., Carini M., Scipione P., Politano M., Rubino G., Reina C., Peccerillo N., Paloscia L., D'Alleva A., Petacchi R., Pignalosa M., Lucchetti D., Di Palma F., La Mastra R. A., Amico A. F., De Filippis M., Fontanella B., Zanini G., Casolo G., Del Meglio J., Parato V. M., Genovesi E., D'Alimonte A., Miglioranza A., Alessandri N., Moscariello F., Mauro C., Sasso A., Caso P., Petrillo C., Napoletano C., Paparoni S. R., Bernardo V., Serdoz R., Rotunno R., Oppo I., Aloisio A., Aurelio A., Licciardello G., Cassaniti L., Francese G. M., Marcassa C., Temporelli P. L., Villani R., Zorzoli F., Mileto F., De Vecchis M., Scolozzi D., Lupi G., Caruso D., Rebulla E., La Fata B., Anselmi M., Girardi P., Borruso E., Ferrantelli G., Sassone B., Bressan S., Capriolo M., Pelissero E., Piancastelli M., Gobbi M., Cocco F., Bruno M. G., Berti S., Lo Surdo G., Tanzi P., De Rosa R., Vilei E., De Iaco M. R., Grassi G., Zanella C., Marullo L., Alfano G., Pelaggi P., Talarico R., Tuccillo B., Irace L., Proietti F., Di Croce G., Di Lorenzo L., Zarrilli A., Bongini M., Ranise A., Aprile A., Fornengo C., Capogrosso V., Tranghese A., Golia B., Marziano A., Roncon L., Picariello C., Bagni E., Leci E., Gregorio G., Gatto F., Piemonte F., Gervasio F., Navazio A., Guerri E., Belmonte E., Marino F., Di Belardino N., Di Nuzzo M. R., Epifani M., Comolatti G., Conconi B., Benea D., Casu G., Merella P., Ammirati M. A., Corrado V. M., Spagnolo D., Caico S. I., Bonizzato S., Margheri M., Corrado L., Antonicelli R., Ferrigno C., Merlino A., Nassiacos D., Antonelli A., Marchese A., Villella A., Bechi S., Lo Bianco F., Bedogni F., Negro L., Donato L., Statile D., Cassin M., Fedele F., Granatelli A., Calcagno S., Politi A., Pani A., De Luca, L, Formigli, D, Meessen, J, Uguccioni, M, Cosentino, N, Paolillo, C, Di Lenarda, A, Colivicchi, F, Gabrielli, D, Gulizia, M, Scherillo, M, Maras, P, Ramani, F, Falcone, C, Passarelli, I, Mauri, S, Calabro, P, Bianchi, R, Di Palma, G, Mascia, F, Vetrano, A, Fusco, A, Proia, E, Aiello, A, Tomai, F, Licitra, R, Petrolini, A, Bosco, B, Magliari, F, Callerame, M, Mazzella, T, Lettica, G, Coco, G, Incao, F, Marinacci, L, D'Addario, S, Tartaglione, S, Ubaldi, S, Sanchez, F, Costa, P, Manca, G, Failla, M, Procaccini, V, Senni, M, Luminita, E, Bonomo, P, Mossa, C, Corda, S, Colavita, A, Trevisonno, G, Vizzari, G, Formaro, C, Nalin, I, De Rosa, F, Fontana, F, Fuscaldo, G, Passamonti, E, Bertella, E, Calvaruso, E, Varani, E, Tani, F, Cicchitelli, G, Paoloni, P, Marziali, A, Campo, G, Tebaldi, M, Biscaglia, S, Di Biase, M, Brunetti, N, Gallotta, A, Mattei, L, Marini, R, Balsemin, F, D'Urbano, M, Naio, R, Vicinelli, P, Arena, G, Mazzini, M, Gigli, N, Miserrafiti, B, Monopoli, A, Mortara, A, Delfino, P, Chioffi, M, Marino, P, Gravellone, M, Barbieri, L, Ledda, A, Geraci, G, Carmina, M, Raisaro, A, Di Giacomo, C, Somaschini, A, Fasano, M, Sannazzaro, M, Arcieri, R, Pantaleoni, M, Leuzzi, C, Gorlato, G, Greco, G, Chiera, A, Ammaturo, T, Malanchini, G, Del Corral, M, Tedesco, L, Pede, S, Urso, L, Piscione, F, Galasso, G, Provasoli, S, Fattore, L, Lucca, G, Cresti, A, Cardillo, A, Fera, M, Vennettilli, F, Gaudio, C, Paravati, V, Caldarola, P, Locuratolo, N, Verlato, R, De Conti, F, Turiano, G, Preti, G, Moretti, L, Silenzi, S, Colonna, G, Picciolo, A, Nicosia, A, Cascone, C, Di Sciascio, G, Mangiacapra, F, Russo, A, Mastroianno, S, Esposito, G, Cosmi, F, D'Orazio, S, Costantini, C, Lanari, A, De Rosa, P, Esposito, L, Bilato, C, Dalla Valle, C, Ceresa, M, Colombo, E, Pennisi, V, Casciola, G, Driussi, M, Bisceglia, T, Scalvini, S, Rivadossi, F, Volpe, M, Comito, F, Scorzoni, D, Grimoldi, P, Lagioia, R, Santoro, D, De Cesare, N, Comotti, T, Poli, A, Martina, P, Musolino, M, Multari, E, Bilardo, G, Scalchi, G, Olivieri, C, Caranci, F, Pavan, D, Ganci, G, Mariani, A, Falchetti, E, Lanzillo, T, Caccavale, A, Bongo, A, Rizzi, A, Favilli, R, Maffei, S, Mallardo, M, Fulgione, C, Bordin, F, Bonmassari, R, Battaia, E, Puzzo, A, Vianello, G, D'Arpino, A, Romei, M, Pajes, G, Petronzelli, S, Ghezzi, F, Brigido, S, Pignatelli, L, Brscic, E, Sori, P, Russo, M, Biancolillo, E, Ignone, G, De Giorgio, N, Campaniello, C, Ponticelli, P, Margonato, A, Gerosa, S, Cutaia, A, Casalicchio, C, Bartolomucci, F, Larosa, C, Spadafina, T, Putignano, A, Se Cristofaro, R, Bernardi, L, Sommariva, L, Celestini, A, Bertucci, C, Marchetti, M, Franceschini Grisolia, E, Ammendolea, C, Carini, M, Scipione, P, Politano, M, Rubino, G, Reina, C, Peccerillo, N, Paloscia, L, D'Alleva, A, Petacchi, R, Pignalosa, M, Lucchetti, D, Di Palma, F, La Mastra, R, Amico, A, De Filippis, M, Fontanella, B, Zanini, G, Casolo, G, Del Meglio, J, Parato, V, Genovesi, E, D'Alimonte, A, Miglioranza, A, Alessandri, N, Moscariello, F, Mauro, C, Sasso, A, Caso, P, Petrillo, C, Napoletano, C, Paparoni, S, Bernardo, V, Serdoz, R, Rotunno, R, Oppo, I, Aloisio, A, Aurelio, A, Licciardello, G, Cassaniti, L, Francese, G, Marcassa, C, Temporelli, P, Villani, R, Zorzoli, F, Mileto, F, De Vecchis, M, Scolozzi, D, Lupi, G, Caruso, D, Rebulla, E, La Fata, B, Anselmi, M, Girardi, P, Borruso, E, Ferrantelli, G, Sassone, B, Bressan, S, Capriolo, M, Pelissero, E, Piancastelli, M, Gobbi, M, Cocco, F, Bruno, M, Berti, S, Lo Surdo, G, Tanzi, P, De Rosa, R, Vilei, E, De Iaco, M, Grassi, G, Zanella, C, Marullo, L, Alfano, G, Pelaggi, P, Talarico, R, Tuccillo, B, Irace, L, Proietti, F, Di Croce, G, Di Lorenzo, L, Zarrilli, A, Bongini, M, Ranise, A, Aprile, A, Fornengo, C, Capogrosso, V, Tranghese, A, Golia, B, Marziano, A, Roncon, L, Picariello, C, Bagni, E, Leci, E, Gregorio, G, Gatto, F, Piemonte, F, Gervasio, F, Navazio, A, Guerri, E, Belmonte, E, Marino, F, Di Belardino, N, Di Nuzzo, M, Epifani, M, Comolatti, G, Conconi, B, Benea, D, Casu, G, Merella, P, Ammirati, M, Corrado, V, Spagnolo, D, Caico, S, Bonizzato, S, Margheri, M, Corrado, L, Antonicelli, R, Ferrigno, C, Merlino, A, Nassiacos, D, Antonelli, A, Marchese, A, Villella, A, Bechi, S, Lo Bianco, F, Bedogni, F, Negro, L, Donato, L, Statile, D, Cassin, M, Fedele, F, Granatelli, A, Calcagno, S, Politi, A, and Pani, A

Subjects
medicine.medical_specialty, animal structures, Population, Myocardial Infarction, Coronary artery disease, Rivaroxaban, Internal medicine, Epidemiology, medicine, Humans, Registries, Myocardial infarction, education, Stroke, education.field_of_study, Aspirin, business.industry, Health Policy, Incidence (epidemiology), medicine.disease, COMPASS trial, Cohort, Cardiology and Cardiovascular Medicine, business, START registry, Mace
Abstract

Aims Recently, the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial demonstrated that dual therapy reduced cardiovascular outcomes compared with aspirin alone in patients with stable atherosclerotic disease. Methods and results We sought to assess the proportion of patients eligible for the COMPASS trial and to compare the epidemiology and outcome of these patients with those without COMPASS inclusion or with any exclusion criteria in a contemporary, nationwide cohort of patients with stable coronary artery disease. Among the 4068 patients with detailed information allowing evaluation of eligibility, 1416 (34.8%) did not fulfil the inclusion criteria (COMPASS-Not-Included), 841 (20.7%) had exclusion criteria (COMPASS-Excluded), and the remaining 1811 (44.5%) were classified as COMPASS-Like. At 1 year, the incidence of major adverse cardiovascular event (MACE), a composite of cardiovascular death, myocardial infarction, and stroke, was 0.9% in the COMPASS-Not-Included and 2.0% in the COMPASS-Like (P = 0.01), and 5.0% in the COMPASS-Excluded group (P Conclusion In a contemporary real-world cohort registry of stable coronary artery disease, most patients resulted as eligible for the COMPASS. These patients presented a considerable annual risk of MACE that consistently increases in the presence of multiple risk factors.

Published
2021

156. In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study

Author

Nazzareno Galiè, Giuseppe Boriani, Stefano Tondi, Gabriele Guardigli, AMI-Co investigators, Elena Berti, Giuseppe Di Pasquale, Marcello Galvani, Giancarlo Piovaccari, Massimo Piepoli, Diego Ardissino, Rubboli A, Daniela Fortuna, Rossana De Palma, Gianluca Campo, Federico Banchelli, Alessandro Navazio, Gianni Casella, Andrea Santarelli, Campo, Gianluca, Fortuna, Daniela, Berti, Elena, De Palma, Rossana, Pasquale, Giuseppe Di, Galvani, Marcello, Navazio, Alessandro, Piovaccari, Giancarlo, Rubboli, Andrea, Guardigli, Gabriele, Galiè, Nazzareno, Boriani, Giuseppe, Tondi, Stefano, Ardissino, Diego, Piepoli, Massimo, Banchelli, Federico, Santarelli, Andrea, and Casella, Gianni

Subjects
Out of hospital, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), business.industry, Health Policy, INTERVENTION REPERFUSION IMPACT COVID 19, Population based, Cardiac mortality, medicine.disease, NO, Oncology, Internal medicine, Concomitant, Pandemic, Internal Medicine, medicine, Observational study, Myocardial infarction, Public aspects of medicine, RA1-1270, business, Research Paper
Abstract

BACKGROUND: The COVID-19 pandemic has put several healthcare systems under severe pressure. The present analysis investigates how the first wave of the COVID-19 pandemic affected the myocardial infarction (MI) network of Emilia-Romagna (Italy). METHODS: Based on Emilia-Romagna mortality registry and administrative data from all the hospitals from January 2017 to June 2020, we analysed: i) temporal trend in MI hospital admissions; ii) characteristics, management, and 30-day mortality of MI patients; iii) out-of-hospital mortality for cardiac cause. FINDINGS: Admissions for MI declined on February 22, 2020 (IRR -19.5%, 95%CI from -8.4% to -29.3%, p=0.001), and further on March 5, 2020 (IRR -21.6%, 95%CI from -9.0% to -32.5%, p=0.001). The return to pre-COVID-19 MI-related admission levels was observed from May 13, 2020 (IRR 34.3%, 95%CI 20.0%-50.2%, p

Published
2021

157. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in europe. the ACVC-EAPCI EORP STEMI registry of the european society of cardiology

Author

Zeymer, U., Ludman, P., Danchin, N., Kala, P., Laroche, C., Sadeghi, M., Caporale, R., Shaheen, S. M., Legutko, J., Iakobsishvili, Z., Alhabib, K. F., Motovska, Z., Studencan, M., Mimoso, J., Becker, D., Alexopoulos, D., Kereseselidze, Z., Stojkovic, S., Zelveian, P., Goda, A., Mirrakhimov, E., Bajraktari, G., Al-Farhan, H., Serpytis, P., Raungaard, B., Marandi, T., Moore, A. M., Quinn, M., Karjalainen, P. P., Tatu-Chitolu, G., Gale, C. P., Maggioni, A. P., Weidinger, F., Sinnaeve, P., Ferrari, R., Karamfilov, K., Lidon, R. -M., Kereselidze, Z., Iakobishvili, Z., Erglis, A., Kedev, S., Dudek, D., Tatu-Chitoiu, G., Shlyakhto, E., Bunc, M., Mourali, M. S., Konte, M., Larras, F., Lefrancq, E. F., Mekhaldi, S., Shuka, N., Pavli, E., Tafaj, E., Gishto, T., Dibra, A., Duka, A., Gjana, A., Kristo, A., Knuti, G., Demiraj, A., Dado, E., Hasimi, E., Simoni, L., Siqeca, M., Sisakian, H., Hayrapetyan, H., Markosyan, S., Galustyan, L., Arustamyan, N., Kzhdryan, H., Pepoyan, S., Zirkik, A., Von Lewinski, D., Paetzold, S., Kienzl, I., Matyas, K., Neunteufl, T., Nikfardjam, M., Neuhold, U., Mihalcz, A., Glaser, F., Steinwender, C., Reiter, C., Grund, M., Hrncic, D., Hoppe, U., Hammerer, M., Hinterbuchner, L., Hengstenberg, C., Delle Karth, G., Lang, I., Winkler, W., Hasun, M., Kastner, J., Havel, C., Derntl, M., Oberegger, G., Hajos, J., Adlbrecht, C., Publig, T., Leitgeb, M. -C., Wilfing, R., Jirak, P., C. -Y., Ho, Puskas, L., Schrutka, L., Spinar, J., Parenica, J., Hlinomaz, O., Fendrychova, V., Semenka, J., Sikora, J., Sitar, J., Groch, L., Rezek, M., Novak, M., Kramarikova, P., Stasek, J., Dusek, J., Zdrahal, P., Polasek, R., Karasek, J., Seiner, J., Sukova, N., Varvarovsky, I., Lazarak, T., Novotny, V., Matejka, J., Rokyta, R., Volovar, S., Belohlavek, J., Siranec, M., Kamenik, M., Kralik, R., Ravkilde, J., Jensen, S. E., Villadsen, A., Villefrance, K., Schmidt Skov, C., Maeng, M., Moeller, K., Hasan-Ali, H., Ahmed, T. A., Hassan, M., Elguindy, A., Farouk Ismail, M., Ibrahim Abd El-Aal, A., El-Sayed Gaafar, A., Magdy Hassan, H., Ahmed Shafie, M., Nabil El-Khouly, M., Bendary, A., Darwish, M., Ahmed, Y., Amin, O. A., Abdelhakim, A., Abosaif, K., Kandil, H., Galal, M. A. G., El Hefny, E. E., El Sayed, M., Aly, K., Mokarrab, M., Osman, M., Abdelhamid, M., Mantawy, S., Ali, M. R., Kaky, S. D., Khalil, V. A., Saraya, M. E. A., Talaat, A., Nabil, M., Mounir, W. M., Mahmoud, K., Aransa, A., Kazamel, G., Anwar, S., Al-Habbaa, A., Abd El Monem, M., Ismael, A., Amin Abu-Sheaishaa, M., Abd Rabou, M. M., Hammouda, T. M. A., Moaaz, M., Elkhashab, K., Ragab, T., Rashwan, A., Rmdan, A., Abdelrazek, G., Ebeid, H., Soliman Ghareeb, H., Farag, N., Zaki, M., Seleem, M., Torki, A., Youssef, M., Allah Nasser, N. A., Rafaat, A., Selim, H., Makram, M. M., Khayyal, M., Malasi, K., Madkour, A., Kolib, M., Alkady, H., Nagah, H., Yossef, M., Wafa, A., Mahfouz, E., Faheem, G., Magdy Moris, M., Ragab, A., Ghazal, M., Mabrouk, A., El-Masry, M., Naseem, M., Samir, S., Reinmets, J., Allvee, M., Saar, A., Ainla, T., Vaide, A., Kisseljova, M., Pakosta, U., Eha, J., Lotamois, K., Sia, J., Myllymaki, J., Pinola, T., Paana, T., Mikkelsson, J., Ampio, M., Tsivilasvili, J., Zurab, P., Agladze, R., Melia, A., Gogoberidze, D., Khubua, N., Totladze, L., Metreveli, I., Chikovani, A., Eitel, I., Poss, J., Werner, M., Constantz, A., Ahrens, C., Tolksdorf, H., Klinger, S., Sack, S., Heer, T., Lekakis, J., Kanakakis, I., Xenogiannis, I., Ermidou, K., Makris, N., Ntalianis, A., Katsaros, F., Revi, E., Kafkala, K., Mihelakis, E., Diakakis, G., Grammatikopoulos, K., Voutsinos, D., Xanthopoulou, I., Mplani, V., Foussas, S., Papakonstantinou, N., Patsourakos, N., Dimopoulos, A., Derventzis, A., Athanasiou, K., Vassilikos, V. P., Papadopoulos, C., Tzikas, S., Vogiatzis, I., Datsios, A., Galitsianos, I., Koutsampasopoulos, K., Grigoriadis, S., Douras, A., Baka, N., Spathis, S., Kyrlidis, T., Hatzinikolaou, H., Kiss, R. G., Nowotta, F., Toth, K., Szabo, S., Lakatos, C., Jambrik, Z., Ruzsa, J., Ruzsa, Z., Rona, S., Toth, J., Vargane Kosik, A., Toth, K. S. B., Nagy, G. G., Ondrejko, Z., Koromi, Z., Botos, B., Pourmoghadas, M., Salehi, A., Massoumi, G., Soleimani, A., Sarrafzadegan, N., Roohafza, H., Azarm, M., Mirmohammadsadeghi, A., Rajabi, D., Rahmani, Y., Siabani, S., Najafi, F., Hamzeh, B., Karim, H., Siabani, H., Saleh, N., Charehjoo, H., Zamzam, L., Al-Temimi, G., Al-Yassin, A., Mohammad, A., Ridha, A., Al-Saedi, G., Atabi, N., Sabbar, O., Mahmood, S., Dakhil, Z., Yaseen, I. F., Almyahi, M., Alkenzawi, H., Alkinani, T., Alyacopy, A., Kearney, P., Twomey, K., Shlomo, N., Beigel, R., Caldarola, P., Rutigliano, D., Sublimi Saponetti, L., Locuratolo, N., Palumbo, V., Scherillo, M., Formigli, D., Canova, P., Musumeci, G., Roncali, F., Metra, M., Lombardi, C., Visco, E., Rossi, L., Meloni, L., Montisci, R., Pippia, V., Marchetti, M. F., Congia, M., Cacace, C., Luca, G., Boscarelli, G., Indolfi, C., Ambrosio, G., Mongiardo, A., Spaccarotella, C., De Rosa, S., Canino, G., Critelli, C., Chiappetta, D., Battista, F., Gabrielli, D., Marziali, A., Bernabo, P., Navazio, A., Guerri, E., Manca, F., Gobbi, M., Oreto, Giuseppe, Andò, Giuseppe, Carerj, Scipione, Saporito, Francesco, Cimmino, Michele, Rigo, F., Zuin, G., Tuccillo, B., Scotto DI Uccio, F., Irace, L., Lorenzoni, G., Meloni, I., Merella, P., Polizzi, G. M., Pino, R., Marzilli, M., Morrone, D., Caravelli, P., Orsini, E., Mosa, S., Piovaccari, G., Santarelli, A., Cavazza, C., Romeo, F., Fedele, F., Mancone, M., Straito, M., Salvi, N., Scarparo, P., Severino, P., Razzini, C., Massaro, G., Cinque, A., Gaudio, C., Barilla, F., Torromeo, C., Porco, L., Mei, M., Iorio, R., Nassiacos, D., Barco, B., Sinagra, G., Falco, L., Priolo, L., Perkan, A., Strana, M., Percuku, L., Berisha, G., Mziu, B., Beishenkulov, M., Abdurashidova, T., Toktosunova, A., Kaliev, K., Serpytis, R., Butkute, E., Lizaitis, M., Broslavskyte, M., Xuereb, R. G., Mercieca Balbi, M., Paris, E., Buttigieg, L., Musial, W., Dobrzycki, S., Dubicki, A., Kazimierczyk, E., Tycinska, A., Wojakowski, W., Kalanska-Lukasik, B., Ochala, A., Wanha, W., Dworowy, S., Sielski, J., Janion, M., Janion-Sadowska, A., Wojtasik-Bakalarz, J., Bryniarski, L., Peruga, J. Z., Jonczyk, M., Jankowski, L., Klecha, A., Michalowska, J., Brzezinski, M., Kozmik, T., Kowalczyk, T., Adamczuk, J., Maliszewski, M., Kuziemka, P., Plaza, P., Jaros, A., Pawelec, A., Sledz, J., Bartus, S., Zmuda, W., Bogusz, M., Wisnicki, M., Szastak, G., Adamczyk, M., Suska, M., Czunko, P., Opolski, G., Kochman, J., Tomaniak, M., Miernik, S., Paczwa, K., Witkowski, A., Opolski, M. P., Staruch, A. D., Kalarus, Z., Honisz, G., Mencel, G., Swierad, M., Podolecki, T., Marques, J., Azevedo, P., Pereira, M. A., Gaspar, A., Monteiro, S., Goncalves, F., Leite, L., Manuel Lopes Dos Santos, W., Amado, J., Pereira, D., Silva, B., Caires, G., Neto, M., Rodrigues, R., Correia, A., Freitas, D., Lourenco, A., Ferreira, F., Sousa, F., Portugues, J., Calvo, L., Almeida, F., Alves, M., Silva, A., Caria, R., Seixo, F., Militaru, C., Ionica, E., Istratoaie, O., Florescu, M., Lipnitckaia, E., Osipova, O., Konstantinov, S., Bukatov, V., Vinokur, T., Egorova, E., Nefedova, E., Levashov, S., Gorbunova, A., Redkina, M., Karaulovskaya, N., Bijieva, F., Babich, N., Smirnova, O., Filyanin, R., Eseva, S., Kutluev, A., Chlopenova, A., Shtanko, A., Kuppar, E., Shaekhmurzina, E., Ibragimova, M., Mullahmetova, M., Chepisova, M., Kuzminykh, M., Betkaraeva, M., Namitokov, A., Khasanov, N., Baleeva, L., Galeeva, Z., Magamedkerimova, F., Ivantsov, E., Tavlueva, E., Kochergina, A., Sedykh, D., Kosmachova, E., Skibitskiy, V., Porodenko, N., Litovka, K., Ulbasheva, E., Niculina, S., Petrova, M., Harkov, E., Tsybulskaya, N., Lobanova, A., Chernova, A., Kuskaeva, A., Kuskaev, A., Ruda, M., Zateyshchikov, D., Gilarov, M., Konstantinova, E., Koroleva, O., Averkova, A., Zhukova, N., Kalimullin, D., Borovkova, N., Tokareva, A., Buyanova, M., Khaisheva, L., Pirozhenko, A., Novikova, T., Yakovlev, A., Tyurina, T., Lapshin, K., Moroshkina, N., Kiseleva, M., Fedorova, S., Krylova, L., Duplyakov, D., Semenova, Y., Rusina, A., Ryabov, V., Syrkina, A., Demianov, S., Reitblat, O., Artemchuk, A., Efremova, E., Makeeva, E., Menzorov, M., Shutov, A., Klimova, N., Shevchenko, I., Elistratova, O., Kostyuckova, O., Islamov, R., Budyak, V., Ponomareva, E., Ullah Jan, U., Alshehri, A. M., Sedky, E., Alsihati, Z., Mimish, L., Selem, A., Malik, A., Majeed, O., Altnji, I., Alshehri, M., Aref, A., Alhabib, K., Aldosary, M., Tayel, S., Abd Alrahman, M., Asfina, K. N., Abdin Hussein, G., Butt, M., Markovic Nikolic, N., Obradovic, S., Djenic, N., Brajovic, M., Davidovic, A., Romanovic, R., Novakovic, V., Dekleva, M., Spasic, M., Dzudovic, B., Jovic, Z., Cvijanovic, D., Veljkovic, S., Ivanov, I., Cankovic, M., Jarakovic, M., Kovacevic, M., Trajkovic, M., Mitov, V., Jovic, A., Hudec, M., Gombasky, M., Sumbal, J., Bohm, A., Baranova, E., Kovar, F., Samos, M., Podoba, J., Kurray, P., Obona, T., Remenarikova, A., Kollarik, B., Verebova, D., Kardosova, G., Alusik, D., Macakova, J., Kozlej, M., Bayes-Genis, A., Sionis, A., Garcia Garcia, C., Duran Cambra, A., Labata Salvador, C., Rueda Sobella, F., Sans Rosello, J., Vila Perales, M., Oliveras Vila, T., Ferrer Massot, M., Baneras, J., Lekuona, I., Zugazabeitia, G., Fernandez-Ortiz, A., Viana Tejedor, A., Ferrera, C., Alvarez, V., DIaz-Castro, O., Agra-Bermejo, R. M., Gonzalez-Cambeiro, C., Gonzalez-Babarro, E., Domingo-Del Valle, J., Royuela, N., Burgos, V., Canteli, A., Castrillo, C., Cobo, M., Ruiz, M., Abu-Assi, E., Garcia Acuna, J., Zeymer, U., Ludman, P., Danchin, N., Kala, P., Laroche, C., Sadeghi, M., Caporale, R., Shaheen, S. M., Legutko, J., Iakobsishvili, Z., Alhabib, K. F., Motovska, Z., Studencan, M., Mimoso, J., Becker, D., Alexopoulos, D., Kereseselidze, Z., Stojkovic, S., Zelveian, P., Goda, A., Mirrakhimov, E., Bajraktari, G., Al-Farhan, H., Serpytis, P., Raungaard, B., Marandi, T., Moore, A. M., Quinn, M., Karjalainen, P. P., Tatu-Chitolu, G., Gale, C. P., Maggioni, A. P., Weidinger, F., Sinnaeve, P., Ferrari, R., Karamfilov, K., Lidon, R. -M., Kereselidze, Z., Iakobishvili, Z., Erglis, A., Kedev, S., Dudek, D., Tatu-Chitoiu, G., Shlyakhto, E., Bunc, M., Mourali, M. S., Konte, M., Larras, F., Lefrancq, E. F., Mekhaldi, S., Shuka, N., Pavli, E., Tafaj, E., Gishto, T., Dibra, A., Duka, A., Gjana, A., Kristo, A., Knuti, G., Demiraj, A., Dado, E., Hasimi, E., Simoni, L., Siqeca, M., Sisakian, H., Hayrapetyan, H., Markosyan, S., Galustyan, L., Arustamyan, N., Kzhdryan, H., Pepoyan, S., Zirkik, A., Von Lewinski, D., Paetzold, S., Kienzl, I., Matyas, K., Neunteufl, T., Nikfardjam, M., Neuhold, U., Mihalcz, A., Glaser, F., Steinwender, C., Reiter, C., Grund, M., Hrncic, D., Hoppe, U., Hammerer, M., Hinterbuchner, L., Hengstenberg, C., Delle Karth, G., Lang, I., Winkler, W., Hasun, M., Kastner, J., Havel, C., Derntl, M., Oberegger, G., Hajos, J., Adlbrecht, C., Publig, T., Leitgeb, M. -C., Wilfing, R., Jirak, P., Ho, C. -Y., Puskas, L., Schrutka, L., Spinar, J., Parenica, J., Hlinomaz, O., Fendrychova, V., Semenka, J., Sikora, J., Sitar, J., Groch, L., Rezek, M., Novak, M., Kramarikova, P., Stasek, J., Dusek, J., Zdrahal, P., Polasek, R., Karasek, J., Seiner, J., Sukova, N., Varvarovsky, I., Lazarak, T., Novotny, V., Matejka, J., Rokyta, R., Volovar, S., Belohlavek, J., Siranec, M., Kamenik, M., Kralik, R., Ravkilde, J., Jensen, S. E., Villadsen, A., Villefrance, K., Schmidt Skov, C., Maeng, M., Moeller, K., Hasan-Ali, H., Ahmed, T. A., Hassan, M., Elguindy, A., Farouk Ismail, M., Ibrahim Abd El-Aal, A., El-Sayed Gaafar, A., Magdy Hassan, H., Ahmed Shafie, M., Nabil El-Khouly, M., Bendary, A., Darwish, M., Ahmed, Y., Amin, O. A., Abdelhakim, A., Abosaif, K., Kandil, H., Galal, M. A. G., El Hefny, E. E., El Sayed, M., Aly, K., Mokarrab, M., Osman, M., Abdelhamid, M., Mantawy, S., Ali, M. R., Kaky, S. D., Khalil, V. A., Saraya, M. E. A., Talaat, A., Nabil, M., Mounir, W. M., Mahmoud, K., Aransa, A., Kazamel, G., Anwar, S., Al-Habbaa, A., Abd El Monem, M., Ismael, A., Amin Abu-Sheaishaa, M., Abd Rabou, M. M., Hammouda, T. M. A., Moaaz, M., Elkhashab, K., Ragab, T., Rashwan, A., Rmdan, A., Abdelrazek, G., Ebeid, H., Soliman Ghareeb, H., Farag, N., Zaki, M., Seleem, M., Torki, A., Youssef, M., Allah Nasser, N. A., Rafaat, A., Selim, H., Makram, M. M., Khayyal, M., Malasi, K., Madkour, A., Kolib, M., Alkady, H., Nagah, H., Yossef, M., Wafa, A., Mahfouz, E., Faheem, G., Magdy Moris, M., Ragab, A., Ghazal, M., Mabrouk, A., El-Masry, M., Naseem, M., Samir, S., Reinmets, J., Allvee, M., Saar, A., Ainla, T., Vaide, A., Kisseljova, M., Pakosta, U., Eha, J., Lotamois, K., Sia, J., Myllymaki, J., Pinola, T., Paana, T., Mikkelsson, J., Ampio, M., Tsivilasvili, J., Zurab, P., Agladze, R., Melia, A., Gogoberidze, D., Khubua, N., Totladze, L., Metreveli, I., Chikovani, A., Eitel, I., Poss, J., Werner, M., Constantz, A., Ahrens, C., Tolksdorf, H., Klinger, S., Sack, S., Heer, T., Lekakis, J., Kanakakis, I., Xenogiannis, I., Ermidou, K., Makris, N., Ntalianis, A., Katsaros, F., Revi, E., Kafkala, K., Mihelakis, E., Diakakis, G., Grammatikopoulos, K., Voutsinos, D., Xanthopoulou, I., Mplani, V., Foussas, S., Papakonstantinou, N., Patsourakos, N., Dimopoulos, A., Derventzis, A., Athanasiou, K., Vassilikos, V. P., Papadopoulos, C., Tzikas, S., Vogiatzis, I., Datsios, A., Galitsianos, I., Koutsampasopoulos, K., Grigoriadis, S., Douras, A., Baka, N., Spathis, S., Kyrlidis, T., Hatzinikolaou, H., Kiss, R. G., Nowotta, F., Toth, K., Szabo, S., Lakatos, C., Jambrik, Z., Ruzsa, J., Ruzsa, Z., Rona, S., Toth, J., Vargane Kosik, A., Toth, K. S. B., Nagy, G. G., Ondrejko, Z., Koromi, Z., Botos, B., Pourmoghadas, M., Salehi, A., Massoumi, G., Soleimani, A., Sarrafzadegan, N., Roohafza, H., Azarm, M., Mirmohammadsadeghi, A., Rajabi, D., Rahmani, Y., Siabani, S., Najafi, F., Hamzeh, B., Karim, H., Siabani, H., Saleh, N., Charehjoo, H., Zamzam, L., Al-Temimi, G., Al-Yassin, A., Mohammad, A., Ridha, A., Al-Saedi, G., Atabi, N., Sabbar, O., Mahmood, S., Dakhil, Z., Yaseen, I. F., Almyahi, M., Alkenzawi, H., Alkinani, T., Alyacopy, A., Kearney, P., Twomey, K., Shlomo, N., Beigel, R., Caldarola, P., Rutigliano, D., Sublimi Saponetti, L., Locuratolo, N., Palumbo, V., Scherillo, M., Formigli, D., Canova, P., Musumeci, G., Roncali, F., Metra, M., Lombardi, C., Visco, E., Rossi, L., Meloni, L., Montisci, R., Pippia, V., Marchetti, M. F., Congia, M., Cacace, C., Luca, G., Boscarelli, G., Indolfi, C., Ambrosio, G., Mongiardo, A., Spaccarotella, C., De Rosa, S., Canino, G., Critelli, C., Chiappetta, D., Battista, F., Gabrielli, D., Marziali, A., Bernabo, P., Navazio, A., Guerri, E., Manca, F., Gobbi, M., Oreto, G., Ando, G., Carerj, S., Saporito, F., Cimmino, M., Rigo, F., Zuin, G., Tuccillo, B., Scotto DI Uccio, F., Irace, L., Lorenzoni, G., Meloni, I., Merella, P., Polizzi, G. M., Pino, R., Marzilli, M., Morrone, D., Caravelli, P., Orsini, E., Mosa, S., Piovaccari, G., Santarelli, A., Cavazza, C., Romeo, F., Fedele, F., Mancone, M., Straito, M., Salvi, N., Scarparo, P., Severino, P., Razzini, C., Massaro, G., Cinque, A., Gaudio, C., Barilla, F., Torromeo, C., Porco, L., Mei, M., Iorio, R., Nassiacos, D., Barco, B., Sinagra, G., Falco, L., Priolo, L., Perkan, A., Strana, M., Percuku, L., Berisha, G., Mziu, B., Beishenkulov, M., Abdurashidova, T., Toktosunova, A., Kaliev, K., Serpytis, R., Butkute, E., Lizaitis, M., Broslavskyte, M., Xuereb, R. G., Mercieca Balbi, M., Paris, E., Buttigieg, L., Musial, W., Dobrzycki, S., Dubicki, A., Kazimierczyk, E., Tycinska, A., Wojakowski, W., Kalanska-Lukasik, B., Ochala, A., Wanha, W., Dworowy, S., Sielski, J., Janion, M., Janion-Sadowska, A., Wojtasik-Bakalarz, J., Bryniarski, L., Peruga, J. Z., Jonczyk, M., Jankowski, L., Klecha, A., Michalowska, J., Brzezinski, M., Kozmik, T., Kowalczyk, T., Adamczuk, J., Maliszewski, M., Kuziemka, P., Plaza, P., Jaros, A., Pawelec, A., Sledz, J., Bartus, S., Zmuda, W., Bogusz, M., Wisnicki, M., Szastak, G., Adamczyk, M., Suska, M., Czunko, P., Opolski, G., Kochman, J., Tomaniak, M., Miernik, S., Paczwa, K., Witkowski, A., Opolski, M. P., Staruch, A. D., Kalarus, Z., Honisz, G., Mencel, G., Swierad, M., Podolecki, T., Marques, J., Azevedo, P., Pereira, M. A., Gaspar, A., Monteiro, S., Goncalves, F., Leite, L., Manuel Lopes Dos Santos, W., Amado, J., Pereira, D., Silva, B., Caires, G., Neto, M., Rodrigues, R., Correia, A., Freitas, D., Lourenco, A., Ferreira, F., Sousa, F., Portugues, J., Calvo, L., Almeida, F., Alves, M., Silva, A., Caria, R., Seixo, F., Militaru, C., Ionica, E., Istratoaie, O., Florescu, M., Lipnitckaia, E., Osipova, O., Konstantinov, S., Bukatov, V., Vinokur, T., Egorova, E., Nefedova, E., Levashov, S., Gorbunova, A., Redkina, M., Karaulovskaya, N., Bijieva, F., Babich, N., Smirnova, O., Filyanin, R., Eseva, S., Kutluev, A., Chlopenova, A., Shtanko, A., Kuppar, E., Shaekhmurzina, E., Ibragimova, M., Mullahmetova, M., Chepisova, M., Kuzminykh, M., Betkaraeva, M., Namitokov, A., Khasanov, N., Baleeva, L., Galeeva, Z., Magamedkerimova, F., Ivantsov, E., Tavlueva, E., Kochergina, A., Sedykh, D., Kosmachova, E., Skibitskiy, V., Porodenko, N., Litovka, K., Ulbasheva, E., Niculina, S., Petrova, M., Harkov, E., Tsybulskaya, N., Lobanova, A., Chernova, A., Kuskaeva, A., Kuskaev, A., Ruda, M., Zateyshchikov, D., Gilarov, M., Konstantinova, E., Koroleva, O., Averkova, A., Zhukova, N., Kalimullin, D., Borovkova, N., Tokareva, A., Buyanova, M., Khaisheva, L., Pirozhenko, A., Novikova, T., Yakovlev, A., Tyurina, T., Lapshin, K., Moroshkina, N., Kiseleva, M., Fedorova, S., Krylova, L., Duplyakov, D., Semenova, Y., Rusina, A., Ryabov, V., Syrkina, A., Demianov, S., Reitblat, O., Artemchuk, A., Efremova, E., Makeeva, E., Menzorov, M., Shutov, A., Klimova, N., Shevchenko, I., Elistratova, O., Kostyuckova, O., Islamov, R., Budyak, V., Ponomareva, E., Ullah Jan, U., Alshehri, A. M., Sedky, E., Alsihati, Z., Mimish, L., Selem, A., Malik, A., Majeed, O., Altnji, I., Alshehri, M., Aref, A., Alhabib, K., Aldosary, M., Tayel, S., Abd Alrahman, M., Asfina, K. N., Abdin Hussein, G., Butt, M., Markovic Nikolic, N., Obradovic, S., Djenic, N., Brajovic, M., Davidovic, A., Romanovic, R., Novakovic, V., Dekleva, M., Spasic, M., Dzudovic, B., Jovic, Z., Cvijanovic, D., Veljkovic, S., Ivanov, I., Cankovic, M., Jarakovic, M., Kovacevic, M., Trajkovic, M., Mitov, V., Jovic, A., Hudec, M., Gombasky, M., Sumbal, J., Bohm, A., Baranova, E., Kovar, F., Samos, M., Podoba, J., Kurray, P., Obona, T., Remenarikova, A., Kollarik, B., Verebova, D., Kardosova, G., Alusik, D., Macakova, J., Kozlej, M., Bayes-Genis, A., Sionis, A., Garcia Garcia, C., Duran Cambra, A., Labata Salvador, C., Rueda Sobella, F., Sans Rosello, J., Vila Perales, M., Oliveras Vila, T., Ferrer Massot, M., Baneras, J., Lekuona, I., Zugazabeitia, G., Fernandez-Ortiz, A., Viana Tejedor, A., Ferrera, C., Alvarez, V., DIaz-Castro, O., Agra-Bermejo, R. M., Gonzalez-Cambeiro, C., Gonzalez-Babarro, E., Domingo-Del Valle, J., Royuela, N., Burgos, V., Canteli, A., Castrillo, C., Cobo, M., Ruiz, M., Abu-Assi, E., and Garcia Acuna, J.

Subjects
Registrie, medicine.medical_specialty, medicine.medical_treatment, Cardiology, Myocardial Reperfusion, 030204 cardiovascular system & hematology, 03 medical and health sciences, Hospital, 0302 clinical medicine, Reperfusion therapy, Percutaneous Coronary Intervention, Internal medicine, Fibrinolysis, medicine, Humans, 030212 general & internal medicine, Myocardial infarction, Registries, Prospective Studies, Prospective cohort study, Observational studies, observational studies, reperfusion therapy, business.industry, Mortality rate, Primary percutaneous coronary intervention, ST-elevation myocardial infarction, Europe, Hospitals, Treatment Outcome, ST Elevation Myocardial Infarction, Percutaneous coronary intervention, medicine.disease, primary percutaneous coronary intervention, Observational studie, 3. Good health, Prospective Studie, Cohort, Conventional PCI, Cardiology and Cardiovascular Medicine, business, Human
Abstract

Aims The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). Methods and results Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset Conclusions The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality.

Published
2021
Full Text
View/download PDF

158. Adjuvant hormonotherapy and cardiovascular risk in post-menopausal women with breast cancer: A large population-based cohort study

Author

Alessandro Navazio, Matteo Franchi, Roberta Tritto, Giovanni Corrao, Luigi Tarantini, Franchi, M, Tritto, R, Tarantini, L, Navazio, A, and Corrao, G

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Heart failure, 030204 cardiovascular system & hematology, Clinical practice, Article, aromatase inhibitors, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, Adjuvant therapy, Medicine, Myocardial infarction, RC254-282, business.industry, Proportional hazards model, Hazard ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Aromatase inhibitor, medicine.disease, Cardiovascular risk, 030220 oncology & carcinogenesis, Cohort, business, Tamoxifen, Cohort study, medicine.drug
Abstract

Simple Summary For post-menopausal women with estrogen-receptor-positive breast cancer, treatment with aromatase inhibitors reduces disease recurrence and mortality, as compared to tamoxifen. Nevertheless, women treated with aromatase inhibitors more often develop hyperlipidemia, hypercholesterolemia and hypertension, which are recognized cardiovascular (CV) risk factors. Concerns about CV safety of aromatase inhibitors had been raised by several studies. Our results showed that adjuvant therapy with aromatase inhibitors of breast cancer women is associated with increased risk of heart failure and combined CV events, and such therapy probably amplifies the “intrinsic” CV risk of the patient. They underline the importance of interdisciplinary collaboration between oncologists and cardiologists in evaluating the risk/benefit ratio of the choice of hormone therapy. Abstract Background: Whether aromatase inhibitors (AIs) increase the risk of cardiovascular (CV) events, compared to tamoxifen, in women with breast cancer is still debated. We evaluated the association between AI and CV outcomes in a large population-based cohort of breast cancer women. Methods: By using healthcare utilization databases of Lombardy (Italy), we identified women ≥50 years, with new diagnosis of breast cancer between 2009 and 2015, who started adjuvant therapy with either AI or tamoxifen. We estimated the association between exposure to AI and CV outcomes (including myocardial infarction, ischemic stroke, heart failure or any CV event) by a Cox proportional hazard model with inverse probability of treatment and censoring weighting. Results: The study cohort included 26,009 women starting treatment with AI and 7937 with tamoxifen. Over a median follow-up of 5.8 years, a positive association was found between AI and heart failure (Hazard Ratio = 1.20, 95% CI: 1.02 to 1.42) and any CV event (1.14, 1.00 to 1.29). The CV risk increased in women with previous CV risk factors, including hypertension, diabetes and dyslipidemia. Conclusions: Adjuvant therapy with AI in breast cancer women aged more than 50 years is associated with increased risk of heart failure and combined CV events.

Published
2021

164. Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure

Author

Gori, Mauro, primary, Marini, Marco, additional, De Maria, Renata, additional, Gonzini, Lucio, additional, Gorini, Marco, additional, Cassaniti, Leonarda, additional, Benvenuto, Manuela, additional, Municinò, Annamaria, additional, Navazio, Alessandro, additional, Ammirati, Enrico, additional, Leonardi, Giuseppe, additional, Pagnoni, Nicoletta, additional, Montagna, Laura, additional, Catalano, Mariarosaria, additional, Midi, Paolo, additional, Floresta, Agata Marina, additional, Pulignano, Giovanni, additional, Maggioni, Aldo P., additional, Tavazzi, Luigi, additional, and Iacoviello, Massimo, additional

Published
2022
Full Text
View/download PDF

167. [ANMCO Position paper: Prescription appropriateness of direct oral anticoagulants for stroke and systemic thromboembolis with non-valvular atrial fibrillation]

Author

David, Mocini, Stefania Angela, Di Fusco, Leonardo, De Luca, Pasquale, Caldarola, Manlio, Cipriani, Marco, Corda, Andrea, Di Lenarda, Alfredo, De Nardo, Giuseppina Maura, Francese, Cosimo, Napoletano, Alessandro, Navazio, Carmine, Riccio, Loris, Roncon, Emanuele, Tizzani, Stefano, Urbinati, Serafina, Valente, Michele Massimo, Gulizia, Domenico, Gabrielli, Fabrizio, Oliva, and Furio, Colivicchi

Subjects
Stroke, Prescriptions, Rivaroxaban, Pyridones, Atrial Fibrillation, Administration, Oral, Anticoagulants, Humans, Dabigatran
Abstract

The prescription appropriateness of direct oral anticoagulants (DOACs [dabigatran, rivaroxaban, apixaban, and edoxaban]) is carefully regulated, taking into account the criteria established in phase III trials and listed in the summary of the product characteristics of the four DOACs. In clinical practice, prescriptions are not always in compliance with established indications. In particular, the use of doses lower than those recommended in drug data sheets is relatively frequent. Literature data show that the inappropriate prescription of DOAC doses causes drug underexposure and an up to three-fold increase in the risk of stroke/transient ischemic attack, systemic thromboembolism, and hospitalizations. Possible causes of the deviation between the dose that should be prescribed and that actually employed may include erroneous prescriptions, an overstated bleeding risk perception, and the presence of frail patients, who were not included in pivotal trials. For these reasons, we summarize DOAC indications and contraindications and suggest the appropriate use of DOACs in common clinical scenarios, in accordance with what international guidelines and national and international health regulatory agencies recommend.

Published
2021

168. A Population-Based Study of Cardiovascular Disease Mortality in Italian Cancer Patients

Author

Isabella Bisceglia, Mario Larocca, Alessandro Navazio, Angela Damato, Carmine Pinto, Lucia Mangone, Pamela Mancuso, Paolo Giorgi Rossi, and Luigi Tarantini

Subjects
Cancer Research, medicine.medical_specialty, Population, cardiotoxicity, cancer therapy, cardiovascular disease, cancer mortality, Disease, Article, Prostate, Survivorship curve, Internal medicine, medicine, education, RC254-282, education.field_of_study, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, medicine.disease, Standardized mortality ratio, medicine.anatomical_structure, Oncology, Cohort, business, Kidney cancer
Abstract

Simple Summary Research suggests that lengthening the prognosis in cancer patients (which is certainly a positive thing) requires greater attention to be paid to the onset of other pathologies. The increase in cardiovascular mortality in cancer patients (due to both exposure to risk factors and the side effects of cytotoxic drugs) requires greater collaboration between oncologists and cardiologists, and the integration of shared follow-up paths. Particular attention to the follow-up of cancer patients can reduce this risk: in the present study, patients presented an excessive risk of cardiovascular mortality only in the first two years from cancer diagnosis. Abstract The present research describes 25 years of cardiovascular mortality in a cohort of patients in Northern Italy. The study included patients with malignant cancer enrolled in the period of 1996–2019, and describes cardiovascular and cancer mortality in relation to sex, age, year of diagnosis, months of survivorship, tumor site, and standardized mortality ratio (SMR). Out of 67,173 patients, 38,272 deaths (57.7%) were recorded: 4466 from cardiovascular disease (CVD) (6.6%), and 28,579 (42.6%) from cancer. The proportion of CVD death increased from 4.5% in the first two years after diagnosis, to 7.3% after more than 10 years, while the proportion of deaths from cancer decreased from 70.5% to 9.4%. The CVD SMR comparing cancer patients with the general population was 0.87 (95% CI: 0.82–0.92) in 1996–1999, rising to 0.95 (95% CI: 0.84–1.08) in 2015–2019, without differences in terms of sex or age. The risk of dying from CVD was higher compared with the general population (SMR 1.31; 95% CI: 1.24–1.39) only in the first two years after diagnosis. The trend over time underscored that CVD deaths increased in patients with breast, bladder, prostate, and colorectal cancers, and, in the more recent period, for kidney cancer and melanoma patients. Our data confirmed that cardiovascular mortality is an important issue in the modern management of cancer patients, suggesting the need for an extensive interdisciplinary approach.

Published
2021

169. Monitoring calcium handling by the plant endoplasmic reticulum with a low-Ca

Author

Enrico, Cortese, Roberto, Moscatiello, Francesca, Pettiti, Luca, Carraretto, Barbara, Baldan, Lorenzo, Frigerio, Ute C, Vothknecht, Ildiko, Szabo, Diego, De Stefani, Marisa, Brini, and Lorella, Navazio

Subjects
Luminescent Proteins, Aequorin, Chloroplasts, Cytosol, Seedlings, Arabidopsis, Animals, Homeostasis, Calcium, Endoplasmic Reticulum
Abstract

Precise measurements of dynamic changes in free Ca

Published
2021

170. Management and outcome of non-ST-elevation acute coronary syndromes in the elderly admitted to spoke hospitals with no cath-lab facility

Author

G Pignatelli, M Calzolari, E. Guerri, S Musto D'amore, A. Navazio, F. Manca, I Colaiori, F Mantovani, and Vincenzo Guiducci

Subjects
medicine.medical_specialty, Cath lab, business.industry, ST elevation, Emergency medicine, Medicine, Cardiology and Cardiovascular Medicine, business
Abstract

Background Current guidelines recommend an early invasive strategy in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS). However, the role of an invasive strategy in elderly patients remains controversial and may be difficult to achieve in spoke hospitals with no cath-lab facility. Purpose We aimed to analyze characteristics and outcomes of patients ≥80 years with NSTE-ACS admitted to spoke hospitals. Methods Observational retrospective study of all consecutive NSTE-ACS patients admitted to two spoke hospitals, where a service strategy (same-day transfer between spoke hospital and hub center with a cath-lab facility to perform coronary angiography) was available. Results From 2013 to 2017, 639 patients were admitted for NSTE-ACS in a spoke hospital of our provincial cardiology network; of these, 181 (28%) were ≥80 years (median 84, IQR 82–89). In the elderly conservative strategy was chosen in 76 patients (42%). When the invasive strategy was chosen, 104 patients (93%) were managed with a Service strategy with no major adverse event observed during the back transfer from the invasive center to the referring spoke center, whereas the rest of the patients (8, 7%) were transferred from the spoke hospital to the hub center and completed their hospital stay without returning to the spoke center. Of patients initially managed with the service strategy, a shift of strategy after the invasive procedure was necessary for 11 (10%) and the patients remained in the hub center. The median time to access to cath-lab was 50 hours (IQR 25–87), with 73 patients (70%) reaching the invasive procedure Conservative strategy was associated with older age, known previous CAD, clinical presentation with symptoms of LV dysfunction, lower EF, renal failure, higher GRACE score, presence of PAD, and atrial fibrillation (all p At 1-year follow-up, the overall survival was significantly higher in patients treated with invasive strategy compared to patients managed conservatively (94%±2 vs. 54%±6, p Conclusion An invasive strategy may confer a survival benefits in the elderly with NSTE-ACS. When the invasive strategy is chosen, the same-day transfer between spoke hospital and hub center with the cath-lab facility (service strategy) is safe and granted the access to cath-lab in a timely fashion even in the elderly. Funding Acknowledgement Type of funding sources: None. Table 1Figure 1

Published
2021
Full Text
View/download PDF

172. Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure

Author

Manuela Benvenuto, Massimo Iacoviello, Nicoletta Pagnoni, Mariarosaria Catalano, Giuseppe Leonardi, Giovanni Pulignano, Luigi Tavazzi, Enrico Ammirati, Laura Montagna, Aldo P. Maggioni, Annamaria Municinò, Mauro Gori, Paolo Midi, Renata De Maria, Lucio Gonzini, Marco Marini, Marco Gorini, Alessandro Navazio, Leonarda Cassaniti, and Agata Marina Floresta

Subjects
Aged, 80 and over, Heart Failure, medicine.medical_specialty, Ejection fraction, business.industry, Network on, Cardiology, Atrial fibrillation, Stroke Volume, medicine.disease, Prognosis, Obesity, Hospitalization, Ageing, Heart failure, Internal medicine, Outpatients, Etiology, medicine, Humans, EPOCH (chemotherapy), Cardiology and Cardiovascular Medicine, business
Abstract

AIMS Ageing and comorbidities are increasing frailty/complexity of heart failure (HF) patients globally. We assessed evolving trends over two decades according to patients' age and time of recruitment in a nationwide cardiology setting in Italy. METHODS AND RESULTS Chronic HF outpatients recruited between 1999 and 2018 (N = 14,823) were divided into 3 cohorts: 1999-2005 (N = 5404); 2006-2011 (N = 3971); 2012-2018 (N = 5448). We analyzed temporal changes in clinical characteristics, therapies, and outcome (1-year all-cause mortality/cardiovascular hospitalization), overall and by age group

Published
2021

175. Monitoring calcium handling by the plant endoplasmic reticulum with a low‐Ca 2+ ‐affinity targeted aequorin reporter

Author

Cortese, Enrico, primary, Moscatiello, Roberto, additional, Pettiti, Francesca, additional, Carraretto, Luca, additional, Baldan, Barbara, additional, Frigerio, Lorenzo, additional, Vothknecht, Ute C., additional, Szabo, Ildiko, additional, De Stefani, Diego, additional, Brini, Marisa, additional, and Navazio, Lorella, additional

Published
2021
Full Text
View/download PDF

180. A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit

Author

Anna Sara Navazio, Monica Basso, Mario Venditti, Carla Nisii, Emanuela Giombini, Carolina Venditti, Giammarco Raponi, Francesco Alessandri, and Antonino Di Caro

Subjects
Pharmacology, biology, medicine.drug_class, business.industry, Ralstonia pickettii, Antibiotics, Biofilm, biology.organism_classification, Intensive care unit, Microbiology, law.invention, Infectious Diseases, Species level, Ralstonia, law, Ralstonia mannitolilytica, medicine, Pharmacology (medical), business, Bacteria
Abstract

The Ralstonia spp. genus is a group of non-fermentative, Gram-negative bacteria often resistant to many antibiotics, which are emerging as opportunistic pathogens frequently associated with infections in hospital settings. We present herein a case of combined R. pickettii and R. mannitolilytica persisting and relapsing bacteraemia, possibly caused by a septic arterial thrombosis secondary to the rupture of an internal carotid artery aneurysm. Microbiology studies showed that both Ralstonia isolates produced biofilm and carried class D oxacillinase genes. When confronted with infections caused by members of the Ralstonia genus, identification to the species level is crucial for correct clinical management, as the two species show different antibiotic susceptibility patterns.

Published
2019
Full Text
View/download PDF

181. Activation of Primary Amines by Copper(I)-Based Lewis Acid Promoters in the Solventless Synthesis of Secondary Propargylamines

Author

Enrico Marcantoni, Fabio Del Bello, Cristina Cimarelli, Federica Navazio, and Federico Vittorio Rossi

Subjects
Primary (chemistry), 010405 organic chemistry, Organic Chemistry, chemistry.chemical_element, Promoter, 010402 general chemistry, 01 natural sciences, Copper, Catalysis, 0104 chemical sciences, chemistry.chemical_compound, Cerium trichloride, Phenylacetylene, chemistry, Organic chemistry, Lewis acids and bases
Abstract

Primary amines are activated by copper(I)-based Lewis acid promoters in an A3-coupling one-pot solventless reaction with aldehydes and phenylacetylene for the synthesis of secondary propargylamines. The reaction is promoted by a CuSO4/NaI system, a practical precursor of the in situ generated effective CuI/I2 system, that worked well, but only in a restricted number of examples. Substitution of I2 with CeCl3·7H2O in a one-pot two-step reaction provided good yields and a wider applicability, with the added value given by a safer procedure.

Published
2019
Full Text
View/download PDF

182. Quantitative Analysis of Plant Cytosolic Calcium Signals in Response to Water Activated by Low-Power Non-Thermal Plasma

Author

Enrico Cortese, Alessandro Galenda, Alessia Famengo, Luca Cappellin, Marco Roverso, Alessio G. Settimi, Manuele Dabalà, Diego De Stefani, Alessandro Fassina, Gianluigi Serianni, Vanni Antoni, and Lorella Navazio

Subjects
plasma torch, plasma activated water, Arabidopsis thaliana, Organic Chemistry, Arabidopsis, Water, aequorin, General Medicine, dielectric barrier discharge, Catalysis, Computer Science Applications, Calcium, Dietary, Inorganic Chemistry, chemical analyses, Cytosol, cytosolic Ca2+ transients, plant calcium signalling, Calcium, Physical and Theoretical Chemistry, Molecular Biology, Spectroscopy
Abstract

Non-thermal plasma technology is increasingly being applied in the plant biology field. Despite the variety of beneficial effects of plasma-activated water (PAW) on plants, information about the mechanisms of PAW sensing by plants is still limited. In this study, in order to link PAW perception to the positive downstream responses of plants, transgenic Arabidopsis thaliana seedlings expressing the Ca2+-sensitive photoprotein aequorin in the cytosol were challenged with water activated by low-power non-thermal plasma generated by a dielectric barrier discharge (DBD) source. PAW sensing by plants resulted in the occurrence of cytosolic Ca2+ signals, whose kinetic parameters were found to strictly depend on the operational conditions of the plasma device and thus on the corresponding mixture of chemical species contained in the PAW. In particular, we highlighted the effect on the intracellular Ca2+ signals of low doses of DBD-PAW chemicals and also presented the effects of consecutive plant treatments. The results were discussed in terms of the possibility of using PAW-triggered Ca2+ signatures as benchmarks to accurately modulate the chemical composition of PAW in order to induce environmental stress resilience in plants, thus paving the way for further applications in agriculture.

Published
2022
Full Text
View/download PDF

183. Chitosan induces Ca

Author

Anna, Zuppini, Barbara, Baldan, Renato, Millioni, Francesco, Favaron, Lorella, Navazio, and Paola, Mariani

Abstract

• Chitosan, a component of the cell wall of many fungi, has been widely used to mimic pathogen attack and has been shown to induce several defence responses. • Here we show that low concentrations (50 µg ml

Published
2021

188. BLITZ‐HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines.

Author

Gulizia, Michele Massimo, Orso, Francesco, Mortara, Andrea, Lucci, Donata, Aspromonte, Nadia, De Luca, Leonardo, Di Tano, Giuseppe, Leonardi, Giuseppe, Navazio, Alessandro, Pulignano, Giovanni, Colivicchi, Furio, Di Lenarda, Andrea, Oliva, Fabrizio, Pajes, G., Felici, A.R., Midi, P., Leonardi, G., Montana, G., Randazzo, V., and Guerri, E.

Subjects
HEART failure, MEDICAL personnel, VENTRICULAR ejection fraction, ECHOCARDIOGRAPHY
Abstract

Aims: To assess adherence to guideline recommendations among a large network of Italian cardiology sites in the management of acute and chronic heart failure (HF) and to evaluate if an ad‐hoc educational intervention can improve their performance on several pharmacological and non‐pharmacological indicators. Methods and results: BLITZ‐HF was a cross‐sectional study based on a web‐based recording system with pop‐up reminders on guideline recommendations used during two 3‐month enrolment periods carried out 3 months apart (Phase 1 and 3), interspersed by face‐to‐face macro‐regional benchmark analyses and educational meetings (Phase 2). Overall, 7218 patients with acute and chronic HF were enrolled at 106 cardiology sites. During the enrolment phases, 3920 and 3298 patients were included, respectively, 84% with chronic HF and 16% with acute HF in Phase 1, and 74% with chronic HF and 26% with acute HF in Phase 3. At baseline, adherence to guideline recommendations was already overall high for most indicators. Among acute HF patients, an improvement was obtained in three out of eight indicators, with a significant rise in echocardiographic evaluation. Among chronic HF patients with HF and preserved or mid‐range ejection fraction, performance increased in two out of three indicators: creatinine and echocardiographic evaluations. An overall performance improvement was observed in six out of nine indicators in ambulatory HF with reduced ejection fraction patients with a significant increase in angiotensin receptor–neprilysin inhibitor prescription rates. Conclusions: Within a context of an already elevated level of adherence to HF guideline recommendations, a structured multifaceted educational intervention could be useful to improve performance on specific indicators. Extending this approach to other non‐cardiology healthcare professionals, who usually manage patients with HF, should be considered. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

189. The ataxia-linked E1081Q mutation affects the sub-plasma membrane Ca2+-microdomains by tuning PMCA3 activity.

Author

Vallese, Francesca, Maso, Lorenzo, Giamogante, Flavia, Poggio, Elena, Barazzuol, Lucia, Salmaso, Andrea, Lopreiato, Raffaele, Cendron, Laura, Navazio, Lorella, Zanni, Ginevra, Weber, Yvonne, Kovacevic-Preradovic, Tatjana, Keren, Boris, Torraco, Alessandra, Carrozzo, Rosalba, Peretto, Francesco, Peggion, Caterina, Ferro, Stefania, Marin, Oriano, and Zanotti, Giuseppe

Published
2022
Full Text
View/download PDF

190. Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy

Author

Ottini, L., Silvestri, V., Saieva, C., Rizzolo, P., Zanna, I., Falchetti, M., Masala, G., Navazio, A. S., Graziano, V., Bianchi, S., Manoukian, S., Barile, M., Peterlongo, P., D’Amico, C., Varesco, L., Tommasi, S., Russo, A., Giannini, G., Cortesi, L., Viel, A., Montagna, M., Radice, P., and Palli, D.

Published
2013
Full Text
View/download PDF

193. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study

Author

Matador-Pci Investigators, Stefano Urbinati, Andrea Di Lenarda, Leonardo De Luca, Fabrizio Poletti, Leonardo Bolognese, Antonietta Ledda, Alessandro Navazio, Andrea Rubboli, Lucio Gonzini, Domenico Gabrielli, Federico Fortuni, and Michele Massimo Gulizia

Subjects
medicine.medical_specialty, medicine.medical_treatment, Aftercare, 030204 cardiovascular system & hematology, New onset, 03 medical and health sciences, 0302 clinical medicine, Percutaneous Coronary Intervention, Fibrinolytic Agents, Internal medicine, Antithrombotic, Atrial Fibrillation, Internal Medicine, medicine, Humans, 030212 general & internal medicine, Prospective Studies, Acute Coronary Syndrome, business.industry, Incidence (epidemiology), Percutaneous coronary intervention, Anticoagulants, Atrial fibrillation, medicine.disease, Patient Discharge, Treatment Outcome, Concomitant, Conventional PCI, Cardiology, business, Mace, Platelet Aggregation Inhibitors, Follow-Up Studies
Abstract

Patients with concomitant atrial fibrillation (AF) and acute coronary syndromes (ACS) do not seem to receive proper antithrombotic therapies and present high rates of adverse clinical events.. We analyzed the follow-up data of the prospective, nationwide MATADOR-PCI registry. We assessed the use of antithrombotic strategies and the incidence of major adverse cardiovascular events (MACE) and net adverse clinical events (NACE) at 6 months, in patients with new-onset or pre-existing AF admitted for ACS and treated with percutaneous coronary intervention (PCI).. Out of the 588 patients enrolled in the registry and discharged alive (287 with pre-existing and 301 with new-onset AF), data at 6 months were obtained for 579 (98.5%) patients. Compared to hospital discharge, the rate of triple antithrombotic therapy was significantly reduced (from 76.4% to 23.6% and from 53.8% to 23.6%; both p0.0001) while dual antithrombotic therapy (DAT) increased (from 11.8% to 56.3% and from 5.8% to 30.9%; both p0.0001) at follow-up, in patients with pre-existing and new-onset AF, respectively. Among patients with a class IA indication to receive oral anticoagulation therapy (OAT), it was prescribed in 91% and 88% of patients with pre-existing and 64% and 62% of new-onset AF, at discharge and follow-up, respectively. At 6 months from discharge the overall rate of MACE was 8.4% and 7.6% (p=0.75), while NACE occurred in 10.8% vs 10.0% (p=0.74) of patients with pre-existing or new-onset AF, respectively.. At follow-up, DAT was the most used antithrombotic strategy for both patients with pre-existing and new-onset AF with concomitant ACS. These two groups of patients presented comparable rates of MACE and NACE at 6 months.

Published
2021

194. Plasma-activated water triggers rapid and sustained cytosolic Ca2+ elevations in arabidopsis thaliana

Author

Manuele Dabalà, Silvia Pettenuzzo, Vanni Antoni, Lorella Navazio, Luca Cappellin, Enrico Cortese, Alessandro Galenda, Alessia Famengo, and Alessio Giorgio Settimi

Subjects
calcium signalling, plasma torch, Arabidopsis thaliana, Aequorin, aequorin, chemistry.chemical_element, Plant Science, Calcium, cytosolic Ca2+ changes, Arabidopsis, plasmaactivated water, reactive oxygen species, reactive nitrogen species, Ecology, Evolution, Behavior and Systematics, plasma-activated water, Calcium signaling, chemistry.chemical_classification, Reactive oxygen species, Ecology, biology, Chemistry, Botany, biology.organism_classification, Cell biology, Cytosol, QK1-989, biology.protein, Intracellular
Abstract

Increasing evidence indicates that water activated by plasma discharge, termed as plasma-activated water (PAW), can promote plant growth and enhance plant defence responses. Nevertheless, the signalling pathways activated in plants in response to PAW are still largely unknown. In this work, we analysed the potential involvement of calcium as an intracellular messenger in the transduction of PAW by plants. To this aim, Arabidopsis thaliana (Arabidopsis) seedlings stably expressing the bioluminescent Ca2+ reporter aequorin in the cytosol were challenged with PAW generated by a plasma torch. Ca2+ measurement assays demonstrated the induction by PAW of rapid and sustained cytosolic Ca2+ elevations in Arabidopsis seedlings. The dynamics of the recorded Ca2+ signals were found to depend upon different parameters, such as the operational conditions of the torch, PAW storage, and dilution. The separate administration of nitrate, nitrite, and hydrogen peroxide at the same doses as those measured in the PAW did not trigger any detectable Ca2+ changes, suggesting that the unique mixture of different reactive chemical species contained in the PAW is responsible for the specific Ca2+ signatures. Unveiling the signalling mechanisms underlying plant perception of PAW may allow to finely tune its generation for applications in agriculture, with potential advantages in the perspective of a more sustainable agriculture.

Published
2021
Full Text
View/download PDF

199. A Simple Multiparametric Score System to Predict In-Hospital Mortality of COVID-19 Patients

Author

Gianfranco Tortorici, Paolo Ortolani, Gabriele Guardigli, Francesco Vitali, Gibiino F, Gianni Casella, Alessandro Corzani, Emanuele D'Aniello, Mezzanotte R, Cimaglia P, Michele Malagù, Giancarlo Piovaccari, Luca Rossi, Ienno Ld, Andrea Rubboli, Navazio A, Marcello Galvani, Daniela Aschieri, Manfrini M, Claudio Rapezzi, Matteo Bertini, Roberto Ferrari, Biagio Sassone, and Ottavio Zucchetti

Subjects
medicine.medical_specialty, In hospital mortality, Coronavirus disease 2019 (COVID-19), business.industry, Ethics committee, Multicenter study, Internal medicine, medicine, Clinical endpoint, Delirium, Observational study, medicine.symptom, Risk assessment, business
Abstract

Background: Several clinical, laboratory and instrumental prognostic indicators for coronavirus disease 2019 (COVID-19) have been found. Combining all the different predictors in a score would make easier and more accurate the risk assessment of COVID-19 patients. To this purpose, we examined a large number of COVID-19 patients. First, we identified the best predictors of in-hospital mortality at admission. Then, we calculated a score system to capture the contribution of the various prognostic indicators. Methods: Prospective multicenter study (ELCOVID) referring to central-northern Italy. This project is registered on ClinicalTrials.gov (identifier: NCT04367129). COVID-19 patients admitted to the hospital in the period May-September 2020 were enrolled. Clinical, laboratory and electrocardiographic (ECG) records were collected at admission. Patients were followed-up and in-hospital mortality constituted the primary endpoint. A risk scoring system to predict prognosis was derived by independent predictors of in-hospital mortality. Findings: A total of 1014 patients fulfilled inclusion criteria. Demographic, clinical, laboratories and ECG characteristics were collected. Median age was 74 (IQR 64-82) years, and most patients were male (61%). During a median follow-up of 12 (IQR 7-22) days, 359 (35%) patients died. Age (HR 2.25, 95%CIs 1.72-2.94, p < 0.001), delirium (HR 2.03, 95%CIs 2.14-3.61, p = 0.012), platelets count (HR 0.91, 95%CIs 0.83-0.98, p = 0.018), D-dimer (HR 1.18, 95%CIs 1.01-1.31, p = 0.002), S1Q3T3 pattern and/or RBBB (HR 1.47, 95%CIs 1.02-2.13, p = 0.039) and ECG signs of previous myocardial necrosis (HR 2.28, 95%CIs 1.23-4.21, p = 0.009) were independently associated to in-hospital mortality. The risk scoring system derived had a moderate discriminatory capability and good calibration. A score value ≥4 had a sensitivity of 78,4% and specificity of 65,2% to predict in-hospital mortality. Interpretation: This score system stratifies prognosis and may be important for the management of COVID-19 patients admitted to the hospital. Trial Registration: ClinicalTrials.gov (identifier: NCT04367129). Funding Statement: None. Declaration of Interests: None declared. Ethics Approval Statement: ELCOVID is a prospective observational study approved by the local Ethics Committee and involves 15 hospitals in the Emilia Romagna and Lazio, two regions in northern and central Italy heavily affected by the pandemic.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results